Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology.
- Dapoxetine is contraindicated with certain medications and health conditions.
- Topical creams should be used sparingly to prevent partner numbness.
- SSRI treatment may cause emotional blunting or decreased libido.
- Tramadol's risk of dependency requires careful medical supervision.
- Mechanical devices can provide temporary ejaculation delay.
- Behavioral training involves specific sex exercises for control.
- Mindfulness and relaxation techniques benefit PE management.
- Proper diagnosis is essential to rule out underlying disorders.
- Incorporate partner feedback to improve treatment results.
- Avoid abrupt discontinuation of prescribed medication.
- Lifestyle modifications can include weight management.
- Ongoing research aims to develop more effective PE treatments.
McMahon CG, Porst H.
Expected duration
Prevalence and correlates of premature ejaculation in a primary care setting: a preliminary cross-sectional study. Premature ejaculation and vardenafil best price erectile dysfunction prevalence and attitudes in the Asia-Pacific region. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. An update of the International Society of Sexual Medicine’s Guidelines for the diagnosis and treatment of premature ejaculation (PE). Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M.
The pause-squeeze technique
A multinational population survey of intravaginal ejaculation latency time. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. Characteristics of men who are bothered by rapid ejaculation: results from clinical intake surveys. Advances in understanding and treating premature ejaculation. Frequency of etiological factors among patients with acquired premature ejaculation: prospective, observational, single-center study. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
- Dapoxetine is taken as needed, usually 1-3 hours before sex for rapid action.
- Topical anesthetics should be used sparingly to avoid numbness of partner.
- SSRIs may cause side effects like nausea, dizziness, or decreased libido.
- Tramadol carries potential for abuse and should only be used under medical supervision.
- Daily use of certain medications may be recommended for persistent PE.
- Psychological counseling helps address performance anxiety contributing to PE.
- Pelvic floor exercises improve control and delay ejaculation naturally.
- Partner involvement in therapy can improve treatment adherence.
- Discontinuing medication abruptly may cause withdrawal symptoms or rebound.
- For some men, combining therapy with lifestyle changes yields better results.
- Over-the-counter remedies should be approached cautiously and discussed with a doctor.
- Research continues into new pharmacological and non-pharmacological treatments.
Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Original | 100mg | 12 Pills | 72.54€ 69.09€ | |
| Cialis Soft Tabs | 20mg | 90 + 6 Pills | 216.71€ 206.39€ | |
| Cialis Generic | 5mg | 360 + 10 Pills | 268.08€ 255.31€ | |
| Kamagra Soft Tabs | 100mg | 180 + 8 Pills | 425.45€ 405.19€ | |
| Tadalista Super Active | 20mg | 120 + 16 Pills | 382.15€ 363.95€ | |
| Levitra Generic | 40mg | 360 + 10 Pills | 704.99€ 671.42€ | |
| Levitra Professional | 20mg | 120 + 4 Pills | 348.44€ 331.85€ | |
| Viagra Original | 100mg | 48 + 4 Pills | 207.15€ 197.29€ | |
| Super Kamagra | 160 mg | 12 Pills | 101.10€ 96.29€ | |
| Cialis Black | 80mg | 180 + 10 Pills | 356.64€ 339.66€ | |
| Cialis Generic | 2.5mg | 10 Pills | 28.51€ 27.15€ | |
| Cialis Professional | 40mg | 10 Pills | 65.09€ 61.99€ | |
| Kamagra | 100mg | 60 + 4 Pills | 201.34€ 191.75€ | |
| Kamagra Soft Tabs | 100mg | 12 Pills | 57.55€ 54.81€ | |
| Cialis Generic | 2.5mg | 20 Pills | 40.73€ 38.79€ | |
| Kamagra | 100mg | 20 Pills | 86.09€ 81.99€ |
Real-life use of the eutectic mixture lidocaine/prilocaine spray in men with premature ejaculation. Abu El-Hamd M. Effectiveness and tolerability of lidocaine 5% spray in the treatment of lifelong premature ejaculation patients: a randomized single-blind placebo-controlled clinical trial.
- Dapoxetine's fast action makes it convenient for on-demand use.
- Topical anesthetics should be used with caution to avoid partner discomfort.
- SSRIs are not approved solely for PE but are widely prescribed off-label.
- Tramadol can interact with other medications, requiring caution.
- Behavioral techniques teach ejaculation control through practice.
- Pelvic exercises improve muscular control over ejaculation.
- Psychological interventions target mental aspects of PE.
- Combining therapies offers the best chance for success.
- Regular monitoring helps track side effects and effectiveness.
- Lifestyle choices, such as diet and exercise, impact sexual health.
- Open dialogue with healthcare providers ensures safe treatment.
- Ongoing research explores novel pharmacological options.
Efficacy and safety of behavioral therapy for premature ejaculation: protocol for a systematic review. Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach.
Additional info
Significance of penile hypersensitivity in premature ejaculation. Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. Association between lifelong premature ejaculation and polymorphism of tryptophan hydroxylase 2 gene in the Han population. The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation.
Psychological causes
Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism. Study of the link between dopamine transporter gene polymorphisms and response to paroxetine and escitalopram in patients with lifelong premature ejaculation. Possible role of serum testosterone, gonadotropins and prolactin in patients with premature ejaculation. The relationship between premature ejaculation and hyperthyroidism. Sihotang RC, Alvonico T, Taher A, Birowo P, Rasyid N, Atmoko W. Pelvic muscle floor rehabilitation as a therapeutic option in lifelong premature ejaculation: long-term outcomes.
| Strategy | Description | Expected Outcome | Time Frame | Additional Notes |
|---|---|---|---|---|
| Mindfulness Meditation | Practice focusing on the present moment to reduce anxiety | Reduced performance anxiety | Weeks to months | Complements other treatments |
| Sensate Focus Exercises | Partner-based touching exercises to build comfort | Increased control and intimacy | Several weeks | Requires partner cooperation |
| Cognitive Behavioral Therapy | Therapy addressing thoughts and anxiety related to sex | Better sexual confidence | Several sessions | Often part of a comprehensive plan |
Transcutaneous neuromuscular electrical stimulation may be beneficial in the treatment of premature ejaculation.
When to call a professional
In a trial conducted in 2020, the effectiveness of TPTNS treatment was compared to sham therapy in a group of 60 men with PE. They underwent 30-min sessions of either TPTNS or sham therapy once a week. At the conclusion of the 12-week treatment period, the average IELT values increased from 40.4 s to 51.25 s for patients receiving TPTNS, while for those treated with sham therapy, the values went from 37.9 s to 42.5 s (P = 0.030) [52]. This study revealed an improvement in IELT scores in the Sham group, even though no electrical current was applied. This suggests that the contact of the TPTNS probe with the body may have induced a placebo effect.
Paroxetine (Paxil, Pexeva)
There were no statistically significant differences observed between patients treated with TPTNS or Sham in terms of the percentage change in IELT scores from pre-to-post-procedure (0.38 ± 0.47 vs. 0.23 ± 0.67, P = 0.415). However, it’s important to note that a major limitation of this study was the absence of randomization, potentially introducing bias in participant selection. The initial outcomes of TPTNS in treating PE appear conflicting, highlighting the need for randomized controlled studies involving large patient cohorts. In recent years, a new approach to treating PE has emerged, involving the use of a masturbation aid device in conjunction with behavioral techniques. Transcutaneous functional electrical stimulation — a novel therapy for premature ejaculation: results of a proof of concept study.
- Topical anesthetic creams temporarily desensitize the penis to delay ejaculation.
- SSRI medications like paroxetine are prescribed off-label for premature ejaculation.
- Dapoxetine is a short-acting SSRI specifically approved for PE treatment.
- Tramadol, an opioid, can help delay ejaculation but carries dependency risks.
- Topical sprays offer quick, localized numbing effects to control ejaculation timing.
- PDE5 inhibitors like sildenafil may improve performance in men with PE and ED.
- Behavioral therapies include the stop-start and squeeze techniques to extend duration.
- Kegel exercises strengthen pelvic muscles, potentially delaying ejaculation.
- Counseling and sex therapy can address psychological causes of PE.
- Combining medication with behavioral techniques enhances treatment effectiveness.
- Herbal supplements lack robust clinical evidence but are used by some for PE.
- Consultation with a healthcare provider is essential to tailor appropriate therapy.
A Novel, on-demand therapy for Lifelong Premature Ejaculation using a Miniature Trans-Perineal Electrical Stimulator, the vPatch® - as-treated analysis. Peyronnet B, Amarenco G, Kerdraon J, Cornu JN, Gamé X.
What causes premature ejaculation?
Premature ejaculation in tadalista 2 5 patients with lower urinary tract symptoms: a systematic review. Chronic prostatitis in premature ejaculation: a cohort study in 153 men. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. Mondaini N, Fusco F, Cai T, Benemei S, Mirone V, Bartoletti R. Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a “Waterloo”. Transcutaneous posterior tibial nerve stimulation: ready for prime time. Giuliano F. Neurophysiology of erection and ejaculation. Puppo V, Puppo G.
Selective Serotonin Reuptake Inhibitors
In a multicenter randomized clinical trial utilizing a parallel group design to assess the effectiveness of the electronic masturbation device known as Myhixel © (MYHIXEL, Seville, Spain) in PE treatment, Rodriguez et al. assigned 52 patients to two treatment groups, with only 40 completing the study. All patients underwent an 8-week Sphincter Control Training program. The sole distinction between the groups was the inclusion of the Myhixel © device. The primary metric was the “fold increase” in IELT.
Male pelvic floor muscles
At the conclusion of the 8-week treatment, the geometric means of IELT demonstrated more favorable outcomes for the device group, albeit without statistical significance (P = 0.11) (an increase of 30 s versus 90 s from baseline in the exercise-only and device groups, respectively). Notably, in the device group, the fold increase in IELT was significantly higher compared to the exercise-only group, at 4.27 versus 2.09, respectively (P = 0.001) [53] (See Table 1 for comparison between the new technologies). While there are treatments for PE that are actually, clinically proven, scientifically significant and FDA cleared (i.e behavioral therapies, topical anesthetics, and certain medications and medical devices), there are also numerous devices and products on the market that claim to treat or prevent PE but lack scientific evidence to support their efficacy (i.e Morari device- #how-it-works, Vaacum constriction devices, male vibrators). It’s crucial to approach any device claiming to treat PE with skepticism and caution unless there is robust scientific evidence supporting its efficacy and safety. Currently, the standards of care in PE treatment are mainly SSRIs and topical anesthetics. Comprehensive review of the anatomy and physiology of male ejaculation: premature ejaculation is not a disease. Transcutaneous electric nerve stimulation to treat patients with premature ejaculation: phase II clinical trial. Aydos MM, Nas I, Önen E. The impact of transcutaneous posterior tibial nerve stimulation in patients with premature ejaculation. Efficacy of Sphincter Control Training and medical device in the treatment of premature ejaculation: a multicenter randomized controlled clinical trial. Tal Golan, Founder & CEO of Virility Medical, for his scientific contribution and Dr. Debby Mir for her scientific editing.
Tricyclic antidepressants
However, the available drug treatments for PE come with limited effectiveness, a range of adverse effects, and a high rate of discontinuation. A definitive cure for PE, or at least therapies allowing for spontaneity during intercourse, remain elusive. Encouragingly, data from studies utilizing newly developed technological techniques and medical devices in PE treatment show promise. Solutions that are drug-free, entail minimal adverse effects, and permit spontaneity during intercourse are on the horizon. However, additional clinical studies would be beneficial in confirming the effectiveness of these therapies, potentially establishing them as possible alternatives to pharmacological PE treatments.
Benzocaine Wipes for PE
This is a review article with no original scientific data. Althof S. Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. Diagnostic and statistical manual of mental disorders: DSM-5. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine AdHoc Committee for the definition of premature ejaculation. Open access funding provided by Technion - Israel Institute of Technology. The authors declare no conflicts of interest related to this review manuscript. Nevertheless, both authors have financial contracts with Virility Medical LTD, while two of the articles among the 53 reviewed in this work, were sponsored by Virility LTD. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material.